KASINGER JAMES R.

CIK 00017081721 companyBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001708172

Recent Transactions

24 trades

Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2024-10-16+18,333→ 18,333 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2024-10-16+30,000→ 30,000 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-10-14$46.28/sh−1,089→ 62,597 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2024-10-13+2,113→ 63,686 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2024-10-13−2,113→ 4,227 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2024-03-20+25,000→ 25,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2024-03-20+33,333→ 33,333 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-03-12$74.44/sh−1,146→ 61,174 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2024-03-11−2,250→ 2,250 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2024-03-11+2,250→ 62,320 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-03-11$78.26/sh−2,801→ 60,070 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2024-03-10−5,500→ 16,500 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2024-03-10+5,500→ 62,871 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-02-20$79.67/sh−1,913→ 57,371 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2024-02-18+3,825→ 59,284 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2024-02-18−3,825→ 7,650 total
Tax Payment
CRISPR Therapeutics AG$CRSP
Common Shares
2023-03-13$43.22/sh−1,022→ 54,844 total
Tax Payment
CRISPR Therapeutics AG$CRSP
Common Shares
2023-03-13$43.22/sh−1,283→ 53,616 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2023-03-11−2,250→ 4,500 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2023-03-11+2,250→ 55,866 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2023-03-10+40,000→ 40,000 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2023-03-10+2,833→ 54,899 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2023-03-10+22,000→ 22,000 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2023-03-10−2,833→ 0 total

Companies

CRISPR Therapeutics AG
General Counsel and Secretary
$CRSP

Recent Filings

Address

C/O CRISPR THERAPEUTICS 105 WEST FIRST STREET

BOSTON, MA, 02127

View on SEC.gov